SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001288123-10-000021
Filing Date
2010-03-18
Accepted
2010-03-18 15:22:26
Documents
1
Period of Report
2010-03-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3451
  Complete submission text file 0001288123-10-000021.txt   5224
Mailing Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010
Business Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010 212-994-8200
ANTIGENICS INC /DE/ (Issuer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ANTIGENICS INC. 3 FORBES RD LEXINGTON MA 02421
Business Address
Valentine Karen (Reporting) CIK: 0001437152 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-29089 | Film No.: 10691414